Mt4 - metallothionein 4 Gene
Also Known as RGD1565500
Species: Rattus norvegicus
Gene Type: protein coding
Gene ID: 498911
Summary
Predicted to enable metal ion binding activity. Predicted to be involved in cellular response to metal ion; cellular zinc ion homeostasis; and detoxification of copper ion. Predicted to act upstream of or within cellular metal ion homeostasis. Predicted to be active in cytoplasm and nucleus. Orthologous to human MT4 (metallothionein 4). [provided by Alliance of Genome Resources, Apr 2022]
Mt4 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001126084.1 | NP_001119556.1 | metallothionein-4 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
metallothionein-4 |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(3)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-50101A | Mavorixafor trihydrochloride | 99.75% | Yes | |
| HY-50101 | Mavorixafor | 99.72% | Yes | |
| HY-50101C | Mavorixafor hydrochloride | 99.64% | Unkown |
Clinical Phase
Bioactive Molecules
(4)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase
|
|---|---|---|---|---|
| HY-177098 | Lepetegravir | Inhibitor | / | Phase 3 |
| HY-N0842 | Bevirimat | Inhibitor | 99.82% | Phase 2 |
| HY-15355 | Loviride | Inhibitor | 99.59% | Phase 2 |
| HY-12108 | S 1360 | Inhibitor | / | Phase 2 |
Pre-clinical Phase
Bioactive Molecules
(34)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-128595 | MT-4 | Inhibitor | 99.84% | Unkown |
| HY-N16050 | Ethyl salvianolate A | Inhibitor | 91.38% | Unkown |
| HY-135856 | SARS-CoV-IN-2 | Inhibitor | 98.66% | Unkown |
| HY-135858 | SARS-CoV-IN-3 | Inhibitor | 99.36% | Unkown |
| HY-137309 | 4-Deoxy-4α-phorbol | / | Unkown | |
| HY-146090 | HIV-1 inhibitor-33 | Inhibitor | / | Unkown |
| HY-10891 | HIV-1 inhibitor-61 | Inhibitor | / | Unkown |
| HY-116240 | 2′,3′-Dideoxy-5-ethyluridine | / | Unkown | |
| HY-120812 | HIV-IN-11 | Inhibitor | / | Unkown |
| HY-122229 | GS-9822 | Inhibitor | / | Unkown |
| HY-125810 | 4'-Ethynyl-2'-deoxyadenosine | Inhibitor | / | Unkown |
| HY-144714 | HIV-1 inhibitor-18 | Inhibitor | / | Unkown |
| HY-144715 | HIV-1 inhibitor-17 | Inhibitor | / | Unkown |
| HY-146015 | HIV-1 inhibitor-21 | Inhibitor | / | Unkown |
| HY-146019 | HIV-1 inhibitor-24 | Inhibitor | / | Unkown |
| HY-146019A | HIV-1 inhibitor-25 | Inhibitor | / | Unkown |
| HY-146091 | HIV-1 inhibitor-34 | Inhibitor | / | Unkown |
| HY-146352 | HIV-1 inhibitor-28 | Inhibitor | / | Unkown |
| HY-146353 | HIV-1 inhibitor-29 | Inhibitor | / | Unkown |
| HY-147723 | HIV-1 inhibitor-39 | Inhibitor | / | Unkown |
| HY-149866 | HIV-1 inhibitor-58 | Inhibitor | / | Unkown |
| HY-152539 | HIV-1 inhibitor-54 | Inhibitor | / | Unkown |
| HY-153583 | HDAC8-IN-4 | Inhibitor | / | Unkown |
| HY-181737 | E3 Ligase Ligand-linker Conjugate 225 | / | Unkown | |
| HY-N12260 | Benanomicin A | Inhibitor | / | Unkown |
| HY-RS08745 | MT4 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-111147 | RDEA-427 | Inhibitor | / | Unkown |
| HY-181034 | NNRT-IN-15 | Inhibitor | / | Unkown |
| HY-182497 | U 95133 | Inhibitor | / | Unkown |
| HY-187361 | PROTAC HIV-1 degrader-1 | Degrader | / | Unkown |
| HY-N11288 | Methyl salvionolate A | Inhibitor | / | Unkown |
| HY-RS19301 | Mt4 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS25792 | Mt4 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-18666 | D77 | Inhibitor | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service